Erlanger Baroness Hospital — Chattanooga, Tennessee

Erlanger Baroness Hospital is a clinical research site located in Chattanooga, Tennessee, United States 37403.

Crixeo Clinical Trials Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Erlanger Baroness Hospital has participated in 5 clinical trials.

Therapeutic areas: Brain Metastases From Non-small Cell Lung Cancer (NSCLC), Pain, Postoperative, Crohns Disease.

Sponsors: NovoCure GmbH, Jessica G Putman, Celularity Incorporated.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Erlanger Baroness Hospital?

Erlanger Baroness Hospital has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Erlanger Baroness Hospital conducted?

Erlanger Baroness Hospital has 5 clinical trials on record. Their work covers Brain Metastases From Non-small Cell Lung Cancer (NSCLC), Pain, Postoperative, Crohns Disease.

Is Erlanger Baroness Hospital accredited by Crixeo Clinical Trials?

Erlanger Baroness Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Erlanger Baroness Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.